Global Health Titans Act: FDA Tightens Grip on Safe Weight-Loss Meds as WHO Elevates Them to Essential Status
A New Era in Health: WHO Adds Mounjaro and Ozempic to Essential Medicines List
The Great Debate: Why WHO Withheld Weight-Loss GLP-1 Drugs from its Essential Medicines List
WHO's Landmark Decision: Revolutionary Diabetes and Weight-Loss Drugs Added to Essential Medicines List
Wegovy's Astonishing Revelation: A Game Changer for Heart Health, Beyond Weight Loss
Wegovy Triumphs: Novo Nordisk's Obesity Drug Significantly Cuts Heart Attack and Stroke Risk, Setting a New Benchmark in Cardiovascular Protection
The Ozempic Obsession: Which U.S. Cities Are Leading the Search for the Weight-Loss Drug?
Wegovy's Game-Changing Heart-Saving Revelation: Redefining Obesity Treatment
The Silent Scourge: Why GLP-1 Drugs Like Ozempic Might Be Hiding a Dental Disaster
The GLP-1 Revolution: Unpacking the Future of Weight Loss
The Alarming Truth About 'Ozempic Teeth': Dentists Sound the Alarm on GLP-1 Side Effects
Beyond Weight Loss: GLP-1 Drugs Chart New Territory Against Addiction
A Breakthrough in Affordability: Ozempic Now Half Price for Cash Customers Through GoodRx Partnership
The Wild West of Weight Loss: Unpacking the Perils of Online Compounded GLP-1s
A New Dawn for Liver Health: FDA Greenlights Revolutionary MASH Treatment
Unlocking Your Weight Loss Journey: Are Medications the Missing Piece?
The FDA Says Ozempic Probably Won't Make You Suicidal
FDA Investigating Link Between Semaglutide and Hair Loss, Suicidal Thoughts
FDA investigates reports of hair loss, suicidal thoughts in people using popular diabetes, weight loss drugs